 |
 |
At the Forefront of Immunodiagnostic
Technology
Dexall Biomedical Labs, Inc. was founded
in 1978, with the goal of developing and manufacturing novel immunodiagnostic
products for physicians, clinical laboratories and hospitals.
A decade later, Dexall has
established itself as a high-tech biomedical company at the forefront of
immunodiagnostic technology. Dexall's unique in-vitro allergy diagnostic
products have gained worldwide acceptance.
Building
on it's knowledge and technology, the Company is expanding its diagnostic
product line into the areas of infectious diseases, autoimmune diseases and
malignancies.
Most of Dexall's products are
based on its patented Acti·Tip®
technology. Dexall's Acti·Tip
enzyme immunoassays are fast, accurate and reliable, and can be performed easier
and with less hands-on time than competitive products.
From research and development to
finished products, Dexall's motto is:
"Innovative Methodology on Proven Technology"
- Dr. Thomas T. Hubscher
(Founder & President)
Dexall is an FDA registered manufacturer
of diagnostic devices and operates under the Good Manufacturing Practice (GMP)
Guidelines.
Located in Gaithersburg, MD, a
suburb of Washington, D.C., Dexall is on Maryland's high-tech biotechnology
corridor, minutes from the National Institute of Health (NIH), the Food and Drug
Administration (FDA) and major universities.
The
Company's products are marketed through distributors in the U.S., Canada, Europe
and South America, Asia and the Middle
East, placing Dexall into the global marketplace.
Distributors
find Dexall's product line to be easy to support and competitively priced, while
end users are drawn to Dexall's advanced technology, which translates to product
accuracy, flexibility, speed and ease of use.
Inquiries are always welcome.
For more detailed product information, technical information, product pricing, please contact:
 |
 |
 |
 |